Recent investigations into the drug are demonstrating promising results regarding body composition . Initially intended for treating type 2 diabetes , this GLP-1 receptor agonist has shown substantial https://thebookmarkage.com/story21461808/semaglutide-research-unlocking-new-body-shaping-potential